Force Health Protection Division

USAMMDA's Force Health Protection Division (FHP), on behalf of the Secretary of the Army as Lead Component and the Surgeon General of the Army under DoD Instruction (DoDI) 6200.02, provides a treatment, diagnostic, or prophylactic capability against high consequence threats when FDA-approved products are unavailable, contraindicated, or not feasible.

FHP Mission: Rapidly provide investigational medical countermeasures for the warfighter.

FHP Role: Establishes and manages FDA-compliant protocols, product procurement, shipment and inventories, regulatory reporting, and interfaces with the Headquarters (HQ) United States Army Medical Research and Development Command (USAMRDC) Institutional Review Board and the Office of Regulated Activities to enable the execution of protocols worldwide, during emergent events or contingency operations. Partners with public and private advanced developers to identify products for portfolio inclusion.

FHP Capabilities: Some FHP protocols address low-probability/high-consequence threats. Others provide a means to treat conditions endemic in areas important to the DoD.

Regulatory Tools: Emergency Use Authorization allows the use of unapproved products for large populations in the event of a declared public health emergency.

Intermediate Population Expanded Access Protocol (EAP) enables the treatment of intermediate sized populations with instructions on FDA-compliant product use and safety data reporting to ensure the best possible support to DoD personnel. Product can be pre-positioned under controlled release where it is most likely to be needed, especially where timing of treatment may be critical.

Force Health Protection 24/7 Emergency Phone: 301-401-2768

Download the Force Health Protection Division flyer